The results showed that the overall survival (OS) of NSCLC patients with high RAD21 mRNA expression was dramatically shorter than that of NSCLC patients with low RAD21 mRNA expression (P = 0.0193) (Fig. 2a). Here, RAD21 is linked to non-small cell lung carcinoma.